Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01258231 · ClinicalTrials.gov registry record
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
A clinical trial of Heart Failure and Atrial Fibrillation, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 3
- Study locations
NCT01258231 is a study of Heart Failure and Atrial Fibrillation that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 4,000 participants, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (96% higher). The trial reports 3 study locations across 2 states.
The verdict
NCT01258231, a study of Heart Failure and Atrial Fibrillation, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
Conditions Studied
Study Locations (3)
Texas
- UT Southwestern Medical Center - Dallas
- Department Texas Heart Institute at St. Luke's Episcopal Hospital - Houston
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2000-08 |
| Est. Completion | 2030-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01258231
The ClinicalTrials.gov registry entry for NCT01258231 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (96% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT01258231 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Texas, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01258231 about?
NCT01258231 is a clinical study titled "Identification of Genomic Predictors of Adverse Events After Cardiac Surgery". This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
What is the current status of trial NCT01258231?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2000-08. Estimated completion is 2030-08.
What conditions does trial NCT01258231 study?
This clinical trial studies the following conditions: Heart Failure, Atrial Fibrillation, Myocardial Infarction, Genetic Predisposition to Disease, Heart; Dysfunction Postoperative, Cardiac Surgery.
Who is sponsoring clinical trial NCT01258231?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01258231 being conducted?
This trial has 3 study locations across Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.